US Transcatheter Heart Valve Replacement Machines Market Report 2017-2018

In a transcatheter heart valve replacement procedure, a collapsible replacement valve is delivered to the damaged valve via a balloon catheter. The balloon catheter...

Tidewater Midstream and Infrastructure Ltd. Announces 6.75% Senior Unsecured Note Offering and Amendment to...

THIS RELEASE IS INTENDED FOR DISTRIBUTION OUTSIDE THE UNITED STATES ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION WITHIN THE UNITED STATESCALGARY, Alberta, Dec. 14,...

FODY Food Co. Signs Deal to Help IBS Sufferers

MONTREAL, QUEBEC--(Marketwired - Dec. 14, 2017) - FODY Food Co. ("FODY"), North America's leader in manufacturing, developing and commercializing of low FODMAP foods for...

Matinas BioPharma Appoints Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A., to Board of Directors

BEDMINSTER, N.J., Dec. 14, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications,...

Akcea Initiates Phase 2 Study of AKCEA-ANGPTL3-LRx in Patients with Hypertriglyceridemia, Type 2 Diabetes...

CAMBRIDGE, Mass., Dec. 14, 2017 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat...

Published Study Reveals NIAGEN® Nicotinamide Riboside is an Effective NAD Precursor to Protect Cardiac...

IRVINE, Calif., Dec. 14, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), a fully integrated, science-based, nutraceutical company devoted to improving the way people age, announced important...

Teva Announces Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE & TASE: TEVA) announced today a comprehensive restructuring plan to significantly reduce its cost base, unify and simplify...

Rubius Therapeutics Strengthens Leadership Team with Appointment of Andrew Oh as Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rubius Therapeutics, a biotechnology company pioneering the creation of a new class of extraordinarily active, ready-to-use and life-changing cellular therapies, today announced...

Samenvatting: Takeda en Seattle Genetics presenteren positieve gegevens van Fase 3 van het onderzoek...

CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) en Seattle Genetics, Inc. (NASDAQ: SGEN) kondigen de presentatie aan van...

The Cove Paradise Island and Tropic Ocean Airways Launch Luxury “Fly & Stay” Program

Tropic Ocean Airways Seaplane Our company takes every measure possible to create a faster, more enjoyable travel experience to this magnificent destination PARADISE ISLAND, Bahamas and...